Fulgent Genetics Inc (FLGT)
Debt-to-capital ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 1,133,230 | 1,136,100 | 1,269,880 | 1,165,880 | 569,387 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $1,133,230K)
= 0.00
Based on the data provided, Fulgent Genetics Inc has consistently maintained a debt-to-capital ratio of 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not utilized any debt to finance its operations relative to its total capital structure during this period. A debt-to-capital ratio of 0.00 implies that the company's capital structure is entirely equity-financed, which may suggest a lower financial risk as there are no debt obligations to service. However, it's important to note that an excessively low debt-to-capital ratio may also mean missed opportunities for leveraging debt to potentially enhance returns for shareholders. Overall, a consistent 0.00 debt-to-capital ratio demonstrates Fulgent Genetics Inc's conservative financial approach in managing its capital structure without relying on debt financing.
Peer comparison
Dec 31, 2024